Lilly and Amgen announced manufacturing collaboration for COVID-19 antibody therapies
On Sept. 17, 2020, Eli Lilly and Amgen announced a global antibody manufacturing collaboration to significantly increase the supply…
-
-
MIT and the Broad Institute Developed Rapid test for COVID-19 showed improved sensitivity
On Sept. 17, 2020, researchers announced a CRISPR-based test developed at MIT and the Broad Institute that can…
-
Quest Diagnostics announced COVID-19 Diagnostic test options for active COVID-19 infection through QuestDirect
On Sept. 17, 2020, Quest Diagnostics announced that individuals can purchase a test to diagnose COVID-19 online, without…
-
3CL protease inhibitor NLC-001 added to COVID-19-focused joint venture between Todos Medical and NLC Pharma
On Sept. 17, 2020, Todos Medical announced that NLC Pharma had added the dietary supplement NLC-001 to its…
-
Atossa Therapeutics received second positive safety assessment in clinical study of AT-301 Coronavirus nasal spray
On Sept. 17, 2020, Atossa Therapeutics announced a positive interim safety assessment from the second cohort of healthy…
-
Roche’s phase III EMPACTA study showed reduced likelihood of ventilation in hospitalised patients with COVID-19 associated pneumonia
On Sept. 17, 2020, Roche announced that the phase III EMPACTA study met its primary endpoint, showing that…
-
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
On Sept. 16, 2020, a study by researchers at La Jolla Institute for Immunology published in the Cell,…
-
New anti-infective drugs had a 14% speed advantage vs other drugs from 2000-2019
On Sept. 15, 2020, the Tufts Center for the Study of Drug Development reported that new anti-infective drugs…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Life Science History | Medical Device
FDA published comparative performance data for COVID-19 molecular diagnostic tests
On Sept. 15, 2020, the FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The…
-
Biotechnology | COVID-19 | Infectious Disease | Influenza | NIH | Vaccine
Vaxess Technologies to develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
-
Soligenix announced publication demonstrating thermostabilization of filovirus vaccine antigens
On Sept. 15, 2020, Soligenix announced publication of nonclinical results characterizing filovirus protein antigens (including for Ebola and…
-
Tonix Pharma enrolled first patient in COV-LOGIC study to assess antibody and T cell responses to SARS-CoV-2
On Sept. 15, 2020,Tonix Pharmaceuticals announced that the first patient was enrolled in the observational COV-LOGIC study (TNX-C001),…
-
UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumonia
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
-
Novavax announced COVID-19 vaccine manufacturing agreement with Serum Institute of India
On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India which…
-
Biotechnology | Disease | Neurology | NIH | Therapeutics
NIH augmented large scale study of Alzheimer’s disease biomarkers
On Sept. 14, 2020, the National Institutes of Health (NIH) announced that it had added funding for more…
-
Mateon global study for Artemisinin intervention against COVID-19 cleared for patient enrollment in India
On Sept. 14, 2020, Mateon Therapeutics announced that its global study based on its ARTI-19 protocol for Artemisinin…
-
Valneva and Dynavax announced commercial supply agreement for inactivated, adjuvanted COVID-19 vaccine
On Sept. 14, 2020, Dynavax Technologies announced a commercial partnership for the supply of Dynavax’s CpG 1018 adjuvant…
-
Biotechnology | COVID-19 | NIH | Therapeutics
Baricitinib in combination with remdesivir reduced time to recovery in hospitalized patients with COVID-19 in ACTT-2 Trial
On Sept. 14, 2020, Eli Lilly and Incyte announced initial data from the Adaptive COVID-19 Treatment Trial (ACTT-2)…
-
Text analysis software track global biothreats, such as COVID-19
On Sept. 14, 2020, at the Pacific Northwest National Laboratory (PNNL) reported that U.S. analysts monitoring global biothreats…
-
Pascal Biosciences and SoRSE Technology announced partnership for cannabinoid drug development and cancer clinical trials
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
-
MediciNova announced intranasal RS virus vaccine vuccessfully induced neutralizing antibodies against RS virus in mice
On Sept. 11, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…
-
Todos Medical announced commercial launch of COVID-19 qPCR test kits in the U.S.
On Sept. 11, 2020, Todos Medical announced that the FDA has added the TODOS 2019-nCoV RT-qPCR Detection Kit…
-
The ACIP updated flu vaccine recommendations for 2020-2021
On Sept. 9, 2020, the American Academy of Family Physicians (AAFP) reviewed and agreed with the Advisory Committee…
-
Valneva announced IXIARO supply contract with the U.S. Government worth up to $166 million
On Sept. 9, 2020, Valneva announced the signing of a new contract, lasting up to three years, with…
-
iBio advanced COVID-19 LicKM-subunit vaccine candidate, IBIO-201
On Sept. 9, 2020, iBio announced that it had selected IBIO-201, its LicKMﾙ-ubunit vaccine, as its leading candidate…
-
Biology | Biotechnology | COVID-19 | Diagnostics | Disease | Infectious Disease | Oncology | Therapeutics
NanoString announced new GeoMx COVID-19 Consortium, part of the GeoMx Translational Leadership Network
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…
-
FDA approved Trelegy Ellipta as first once-daily single inhaler triple therapy for treatment of both asthma and COPD in the U.S.
On Sept. 10, 2020, GlaxoSmithKline and Innoviva announced the U.S. Food and Drug Administration (FDA) had approved a…
-
LabCorp launched first combined test for Covid-19, flu and RSV in time for flu season
On Sept. 8, 2020, LabCorp announced the launch of the first testing method to simultaneously detect COVID-19, influenza…
-
INOVIO added Thermo Fisher Scientific to global manufacturing consortium
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
-
Biopharma leaders united to stand with science
On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
